Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MENLO PARK, CA--(Marketwired - Jul 1, 2013) - AntriaBio, Inc. (OTCQB: ANTB), a clinical-stage biopharmaceutical company developing therapies for the treatment of diabetes, announced today that as a...
-
MENLO PARK, CA--(Marketwire - Feb 19, 2013) - AntriaBio, Inc. (OTCQB: ANTB) is pleased to announce the appointment, on January 31, 2013, of two new members to its management team: Nevan Elam, as...
-
MENLO PARK, CA--(Marketwire - Feb 8, 2013) - AntriaBio, Inc. ("AntriaBio") today announced that FINRA has approved a change of the Company's stock ticker symbol. Effective today, the Company's...
-
MENLO PARK, CA--(Marketwire - Feb 6, 2013) - AntriaBio Delaware, Inc. f/k/a AntriaBio, Inc. ("AntriaBio Delaware") (OTCQB: FMYY), a biopharmaceutical company developing novel therapeutics for the...
-
MENLO PARK, CA--(Marketwire - Feb 6, 2013) - AntriaBio Delaware, Inc. f/k/a AntriaBio, Inc. ("AntriaBio Delaware"), a biopharmaceutical company developing novel therapeutics for the diabetes...
-
MENLO PARK, CA--(Marketwire - Jan 7, 2013) - AntriaBio, Inc., a biopharmaceutical company developing novel therapeutics for the diabetes market, is pleased to announce the acquisition of the...